✦ LIBER ✦

Burnout, staff support, and coping in Pediatric Oncology

✍ Scribed by M. Liakopoulou; I. Panaretaki; V. Papadakis; A. Katsika; J. Sarafidou; H. Laskari; I. Anastasopoulos; G. Vessalas; D. Bouhoutsou; V. Papaevangelou; S. Polychronopoulou; S. Haidas

Publisher: Springer-Verlag
Year: 2007
Tongue: English
Weight: 155 KB
Volume: 16
Category: Article
ISSN: 0941-4355
DOI: 10.1007/s00520-007-0297-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Burnout and collegial support in state p

Burnout and collegial support in state psychiatric hospital staff

✍ Patrick W. Corrigan; E. Paul Holmes; Daniel Luchins 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 597 KB

Exploration of a self-protective strateg

Exploration of a self-protective strategy in pediatric oncology staff

✍ Grootenhuis, Martha A.; van der Wel, Monique; de Graaf-Nijkerk, Jojet; Last, Bob 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 805 KB

Reciprocity and burnout in direct care s

Reciprocity and burnout in direct care staff

✍ John Rose; Teresa Madurai; Kate Thomas; Brigid Duffy; Jan Oyebode 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Challenge of supportive surgical care in

Challenge of supportive surgical care in pediatric oncology

✍ Peter W. Dillon 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 2 views

The advent of aggressive treatment protocols and the development of new techniques and procedures now require that the pediatric surgeon be an integral part of all aspects of pediatric oncology care. Supportive care issues, rather than primary tumor management decisions, now dominate the pediatric s

Pediatric oncology in Amsterdam

✍ Coppes-Zantinga, Arty R. ;Coppes, Max J. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB 👁 1 views

Brachytherapy in pediatric oncology

✍ Quon, Harry 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB

{ Sylvain Baruchel is the Principal Investigator of an industry sponsored study (Schering-Plough). He receives no monetary compensation. Grant sponsor: Temodal 1 (the manufacturers of temozolomide), Schering Plough, Inc. (for the Phase I Clinical Trial).